Socioeconomic status and survival of persons with AIDS before and after the introduction of highly active antiretroviral therapy

被引:60
|
作者
Rapiti, E [1 ]
Porta, D [1 ]
Forastiere, F [1 ]
Fusco, D [1 ]
Perucci, CA [1 ]
机构
[1] Lazio Reg Hlth Author, Dept Epidemiol, Rome, Italy
关键词
acquired immunodeficiency syndrome; socioeconomic status; survival; intravenous drug use; gender;
D O I
10.1097/00001648-200009000-00003
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We estimated the AIDS survival by neighborhood socioeconomic status before (1993-1995) and after (1996-1997) the introduction of highly active antiretroviral therapy in Rome, Italy, in a retrospective cohort of persons with AIDS followed through July 31, 1998. Participants included 1,474 persons with AIDS residing in Rome who were diagnosed in 1993-1997. We calculated hazard ratios (HRs) of death for two diagnostic periods (before and after highly active antiretroviral therapy was introduced) by neighborhood socioeconomic status categorized into four levels (level I = highest socioeconomic status), using the Cox model and adjusting fur gender, age, intravenous drug use, CD4 cell count at diagnosis, AIDS-defining disease, and hospital of diagnosis. Thirty-four per cent of persons with AIDS (N = 503) had survived as of mid-1998. For persons with AIDS diagnosed in 1993-1995, we found little difference in the risk of death by neighborhood socioeconomic status. For 1996-1997, the risk of death was greater for persons with lower neighborhood socioeconomic status, especially for levels III and IV [HR = 2.81 (95% confidence interval = 1.38-5.76), and HR = 2.55 (95% confidence interval = 1.27-5.14), respectively, compared with level I]. Stratified analyses showed that the greatest difference was found for women and drug users. In conclusion, even in a country with universal health coverage that Provides therapy at no cost, differences in survival of persons with AIDS have emerged by neighborhood socioeconomic status since highly active antiretroviral therapy was introduced. Inequalities in health care access or in medical management, or poor adherence to treatment, could explain the observed heterogeneity.
引用
收藏
页码:496 / 501
页数:6
相关论文
共 50 条
  • [1] AIDS mortality before and after the introduction of highly active antiretroviral therapy:: does it vary with socioeconomic group in a country with a National Health System?
    Borrell, Carme
    Rodriguez-Sanz, Maica
    Pasarin, M. Isabel
    Brugal, M. Teresa
    Garcia-de-Olalla, Patricia
    Mari-Dell'Olmo, Marc
    Cayla, Joan
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2006, 16 (06): : 601 - 608
  • [2] Toxoplasmic encephalitis in AIDS-patients before and after the introduction of highly active antiretroviral therapy (HAART)
    T. R. Kiderlen
    O. Liesenfeld
    D. Schürmann
    T. Schneider
    European Journal of Clinical Microbiology & Infectious Diseases, 2011, 30 : 1521 - 1525
  • [3] Toxoplasmic encephalitis in AIDS-patients before and after the introduction of highly active antiretroviral therapy (HAART)
    Kiderlen, T. R.
    Liesenfeld, O.
    Schuermann, D.
    Schneider, T.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2011, 30 (12) : 1521 - 1525
  • [4] Characteristics and outcome of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy
    Berenguer, Juan
    Miralles, Pilar
    Ribera, Jose Maria
    Rubio, Rafael
    Valencia, Eulalia
    Mahillo, Beatriz
    Pintado, Vicente
    Palacios, Rosario
    Montes, Maria Luisa
    Tellez, Maria Jesus
    La Cruz, Jose
    Torre-Cisneros, Julian
    Rodriguez-Arrondo, Francisco
    Sepulveda, Maria Antonia
    Gutierrez, Felix
    Peralta, Galo
    Boix, Vicente
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 47 (04) : 422 - 428
  • [5] The effect of hepatitis C on progression to AIDS before and after highly active antiretroviral therapy
    Dorrucci, M
    Valdarchi, C
    Suligoi, B
    Zaccarelli, M
    Sinicco, A
    Giuliani, M
    Vlahov, D
    Pezzotti, P
    Rezza, G
    AIDS, 2004, 18 (17) : 2313 - 2318
  • [6] Highly active antiretroviral therapy and socioeconomic inequalities in AIDS mortality in Spain
    Harper, Sam
    Lynch, John
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2007, 17 (02): : 231 - 231
  • [7] Changes in causes of death and associated conditions among persons with HIV/AIDS after the introduction of highly active antiretroviral therapy in Taiwan
    Lu, Tsung-Hsueh
    Chang, Hong-Jen
    Chen, Long-Shen
    Chu, Miao-Hui
    Ou, Nai-Ming
    Jen, Ian
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2006, 105 (07) : 604 - 609
  • [8] Enteric parasitic infections in HIV/AIDS patients before and after the highly active Antiretroviral therapy
    Rodrigues Bachur, Tatiana Paschoalette
    Vale, Josias Martins
    Branco Coelho, Ivo Castelo
    Bezerra Sales de Queiroz, Telma Regia
    de Souza Chaves, Cristina
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2008, 12 (02): : 115 - 122
  • [9] Hepatotoxicity after introduction of highly active antiretroviral therapy
    Rodríguez-Rosado, R
    García-Samaniego, J
    Soriano, V
    AIDS, 1998, 12 (10) : 1256 - 1256
  • [10] Sarcoidosis after highly active antiretroviral therapy in a patient with AIDS
    Pascual, JC
    Belinchón, I
    Silvestre, JF
    Vergara, G
    Blanes, M
    Bañuls, J
    Betlloch, I
    Boix, V
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2004, 29 (02) : 156 - 158